
About
Europe’s healthcare systems are facing mounting challenges, from workforce shortages to the digital divide, health inequalities to intricate webs of regulatory frameworks – all of which are compounded by the need for a type of competitiveness that is not attained at the expense of social good. These issues demand a rethinking of how health systems operate and adapt to future demands.
At the beginning of this new institutional cycle, the European Commission has the opportunity to keep health systems at the heart of two policy goals: maintain the European footprint in innovation and prosperity, and ensure preparedness and resilience by leveraging lessons learned during the COVID-19 pandemic; both policy goals are interconnected. With various research strongly supporting the return on investment in health rather than it being a cost, a rethinking of perspectives and redesign of systems are critical.
Citizens are calling for a Europe where people can live, work and age in sustainable and healthy environments. In rising to the challenge and by focusing on healthier people, Europe can therefore build more resilient societies.
This event aims to chart a course toward resilient, sustainable, and innovative healthcare systems which can adapt to Europe’s evolving demands while contributing to its societal and environmental goals.
This event takes place in Brussels and is also available to a wider audience via livestream. Follow us on Twitter, LinkedIn or Instagram, and join the #SustainableLivelihoodsSummit discussion!
Our events include photos, audio and video recording that we might use for promotional purposes. By registering you expressly confirm that you have read and understood Friends of Europe privacy policy. Should you have any questions, please contact us on privacy@friendsofeurope.org.
PHOTO CREDIT: Shutterstock|MMD Creative
Schedule
European health systems have been under heavy strain due to increased financial pressure and a challenging economic climate for years. The Covid-19 pandemic exacerbated the problem and amplified it to the political agenda. At the onset of this institutional cycle, Europe faces the effects and intersection between long-standing challenges, such as health and social care workforce shortages, stagnating or even shrinking wages and an ageing population, and multiple competing political priorities. The current situation is thus drastically reducing policymakers’ room for manoeuvre and hampering Europe’s capacity to fully recover from the pandemic’s effect on citizens’ livelihoods.
The completion of the European Health Union represents a great opportunity to trigger a multiplying effect in health systems. Improving access to the most advanced treatments and reducing the barriers that currently separate national health systems will enable Europeans to fully benefit from the Single Market. In addition, supporting the healthcare innovation landscape, already a major source of R&D investments and patents in Europe, by reducing administrative burden and creating stable, consistent rules will drive industry competitiveness, making the business case for retaining manufacturing in Europe.
High-quality, citizen-centric care should be the north star of health policy in the institutional cycle. Strengthening innovation in the European life sciences sector will not only deliver improved long-term value to citizens’ health and security but also serve as an economic driver for Europe. To develop a comprehensive strategy for the sector, Europe must balance its competitiveness goals with thorough assessments of citizens’ health needs; this involves prioritising health promotion, raising health standards, reducing disease burdens and empowering individuals to take greater control over their health and wellbeing.
- How can meaningful stakeholder alliances accelerate the shift from a disease-reactive model of care towards an ecosystem that proactively advocates for disease prevention and health promotion?
How can healthcare innovation improve the long-term quality and accessibility of care? - What are the missing steps to a patient-centred Health Union?
- How can Europe leverage its health sector to drive sustainable economic growth?
Europe’s health ecosystem is operating under unprecedented challenges. With workforce shortages, complex regulatory frameworks, health inequities and barriers in health technology infrastructures among others – a disruptive reimagining of health in Europe is needed. How can we redefine the future of health and realise our vision for a healthier Europe?
In recent years, the use of digital technologies and artificial intelligence (AI) in health has been lauded for its great potential in increasing efficiency, improving diagnosis and treatment and optimising resources amidst workforce challenges. Still, even with the European Commission’s ambitions towards a Digital Single Market and meeting the targets for Europe’s Digital Decade, there remain major barriers hindering the EU’s ability to accelerate the implementation of solutions that effectively adsdress unmet health needs across the continent.
As the EU aims to take a cross-cutting approach to strengthen capacity building and harness the power of digital technologies and AI to optimise clinical outcomes and save lives, EU leaders and innovators face the responsibility of deploying solutions that are both clinically safe, interoperable and environmentally sustainable. Furthermore, they must also be able to reconcile these technological innovations with keeping citizens at the heart of the digital transition – by aligning with the human aspects such as data governance, the digital divide, occupational burnout and inclusivity and algorithmic bias among others.
- Is the EU on a path towards digital health sovereignty and open strategic autonomy (OSA)?
- How can we re-design health systems in such a way that empowers people within a digital ecosystem?
- How can the EU reinforce a more proactive and integrated strategy for the European Health Data Space (EHDS) whilst complying with the EU AI Act?
Speakers

CEO of HEALTH.AI, the Global Agency for Responsible AI in Health (formally known as I-DAIR), President of ‘UNITE Parliamentarians Network for Global Health’ and 2015-2016 European Young Leader (EYL40)
Prior to assuming his current role as CEO of HEALTH.AI (formally known as I-DAIR), an organisation that seeks to enable and improve access to inclusive, impactful and responsible research into digital health and artificial intelligence (AI), Ricardo Baptista Leite served as a member of the Portuguese national parliament’s health committee. He also founded the UNITE global network of parliamentarians, present in over 100 countries and active in tackling infectious diseases. Leite was a practising physician for seven years and has also held an infectious diseases residency at the WHO. He was a medical volunteer during the COVID-19 pandemic and at the Lviv Regional Hospital in Ukraine in the summer of 2022. He has an active role on several scientific and advisory boards of health, including as Chair of the Global Health Policy Lab, a collaborative between the University Medicine Berlin and Harvard University, and Chair of the Centre for Global Health at NOVA University in Portugal.

CEO of EURORDIS – Rare Diseases Europe

Global Head of External Partnerships & Head of Oncology Therapeutic Area in Preclinical Safety, Novartis Institutes for BioMedical research (NIBR)
Salah-Dine Chibout is Global Head of External Partnerships and Head of Oncology Therapeutic Area in Preclinical Safety for NIBR, where he is responsible for the Oncology portfolio’s safety strategy from target identification to market access. Until 2019, Salah-Dine was leading the Therapeutic Areas in Preclinical Safety. In this role, he was responsible for defining all regulatory required toxicity studies, generating the relevant regulatory documents and ensuring efficient interactions with health authorities. In addition, Salah-Dine is leading the External Partnerships department, being responsible for the outsourcing of toxicology activities and interactions with academics for preclinical safety. He represents Novartis at the EFPIA Science and Innovation Board and is the Chair of the Research & Innovation Strategy Group (RIS).

Executive Director of the Movement Health Foundation and co-chair of the strategic partners’ inititiative for Data and Digital Health at the World Health Organization (WHO)
Bogi Eliasen is the Executive Director of the Movement Health Foundation and a senior professional in global health innovation, with a focus on digital transformation and preventive care. He initiated the FarGen project in the Faroe Islands and launched the Nordic Health Movement 2030. Eliasen co-chairs the World Health Organization’s Strategic Partners’ Initiative for Data and Digital Health and serves on the World Economic Forum’s Strategic Advisory Group on Digital Healthcare Transformation. He is also a Richard von Weizsäcker Fellow at the Robert Bosch Academy and an Honorary Fellow in Futures of Health at the Copenhagen Institute for Futures Studies.

Vice Chair of the European Parliament Committee on the Environment, Climate and Food Safety and European Young Leader (EYL40)
András Tivadar Kulja is a surgeon and digital-health expert who was elected to the European Parliament in June 2024 on the ticket of Hungary’s opposition Tisza Party. With 360,000 followers on TikTok, he has Hungary’s most widely-viewed health-education channel. Kulja used his high social media profile to counter disinformation during the COVID-19 pandemic. Inspired to enter politics after attending an opposition rally in April 2024, Kulja gave up his hospital posts to speak freely about Hungary’s healthcare problems. He is a Vice-Chair of the European Parliament Committee on the Environment, Climate, and Food Safety and a member of the Committee on Public Health, where he advocates for a stronger EU role in promoting healthcare reform.

Minister of Health of the Republic of Poland

General Manager for Spain and Portugal at Bristol Myers Squibb (BMS)

Secretary of State for Health of Spain

Facilitator
Tamsin Rose is a facilitator who was until recently a senior fellow for health at Friends of Europe. Having studied international relations, she has 25 years of experience working across the European continent from Ireland to Mongolia. A natural communicator, Tamsin has been a radio reporter, worked on press for the EU Delegation in Moscow and is currently a member of the external speaker team for the European Commission Directorate-General for Communication, describing how the EU works and key policies to visitor groups from around the world. Since 2002, she has specialised in public health and public participation issues, serving as the Secretary General of the European Public Health Alliance (EPHA), and providing strategic advice for health groups on how to engage successfully with the EU.

Member of the European Parliament Committee on Public Health and chair of the Intergroup on Cancer and Rare Diseases, former Romanian health minister and European Young Leader (EYL40)
Vlad Voiculescu is a member of the European Parliament, health policy expert and patient advocate, who until recently has served as the Romanian minister of health. After pursuing a career in finance, Voiculescu became active in public service, serving as the Romanian Finance Minister’s chief of staff before becoming the minister of health in the Dacian Cioloș government. He has been involved in patient advocacy, both at the national and European levels for over a decade. Voiculescu is the founder of an international network of volunteers that helped over 2,500 cancer patients receive essential medicines that were missing in Romania, a story that featured in the HBO documentary The Network’. He is also the Co-Founder of MagiCAMP, which seeks to provide support to children diagnosed with cancer and other serious illnesses. For this work, the European Parliament awarded Voiculescu its ‘European Citizen’s Prize.’

CEO of the European Cancer Organisation (ECO)
Elisabetta Zanon is the Chief Executive Officer of the European Cancer Organisation and a senior professional with over 20 years of experience in European affairs, during which she has shaped health policy and led impactful communication campaigns. She previously served as Director of European Union Public Affairs and Advocacy at the Alliance for Regenerative Medicine, and as Director of Advocacy at the European Society of Cardiology, where she launched the European Society of Cardiology Patient Forum and contributed to European Union-funded research initiatives. Zanon also established and directed the National Health Service European Office in Brussels for a decade.
Partners
Co-organised with
Activities
Re-imagining Europe's health systems
Next event In person & livestreamed

- Area of Expertise
- Sustainable Livelihoods
Health check for a competitive medical technology sector in Europe
Past event In person

- Area of Expertise
- Sustainable Livelihoods
Healthy ageing for Europe's future: the value of adult immunisation
Past event In person & livestreamed

- Area of Expertise
- Sustainable Livelihoods
Europe’s competitiveness: learnings from the healthcare sector
Past event In person & livestreamed

- Area of Expertise
- Sustainable Livelihoods
Financing the green and just transition: towards further partnerships…
- Category
- #CriticalThinking
- Author
- By Sebastián Nieto-Parra
Reclaiming medicines and health innovation for our health
- Category
- #CriticalThinking
- Author
- By Els Torreele
Hidden biases in public health research: why we are failing our most…
- Category
- #CriticalThinking
- Author
- By Marthe De Boevre
Something we can all agree on? Prioritising food waste reduction
- Category
- #CriticalThinking
- Author
- By Jack McQuibban

- Area of Expertise
- Sustainable Livelihoods

- Area of Expertise
- Sustainable Livelihoods

- Area of Expertise
- Sustainable Livelihoods

- Area of Expertise
- Sustainable Livelihoods
Continue
the debate on
- Debating Europe